Skip to content

Search for:

REspiratory Syncytial virus Consortium in EUrope

Search for:

Home
Project
Participants
- Partners
- Affiliated Partners
- ISAG
- EAC
- PAB
Parents/Patients
- RSV Patient Network
- Clinical Studies
Publications
Dissemination
Contact

Establishing the Value and Strategies for Respiratory Syncytial Virus (RSV) Control: The European RSV Consortium (RESCEU)

Mark Miller

Full article here.

Post navigation

Previous PostPrevious Adenovirus vector containing RSV preF induces neutralizing antibodies

Next PostNext Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study

Newsletter

I have read and agree privacy policy

Leave this field empty if you're human:

Twitter

Tweets by RESCEUproject

ACKNOWLEDGEMENT

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement Nº 116019. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Legal notice / Private policy

© 2025 RESCEU – REspiratory Syncytial virus Consortium in EUrope

Top